Muñoz-Garcia, J.; Vargas-Franco, J.W.; Royer, B.B.-L.; Cochonneau, D.; Amiaud, J.; Heymann, M.-F.; Heymann, D.; Lézot, F.
Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma. Cancers 2022, 14, 1765.
https://doi.org/10.3390/cancers14071765
AMA Style
Muñoz-Garcia J, Vargas-Franco JW, Royer BB-L, Cochonneau D, Amiaud J, Heymann M-F, Heymann D, Lézot F.
Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma. Cancers. 2022; 14(7):1765.
https://doi.org/10.3390/cancers14071765
Chicago/Turabian Style
Muñoz-Garcia, Javier, Jorge William Vargas-Franco, Bénédicte Brounais-Le Royer, Denis Cochonneau, Jérôme Amiaud, Marie-Françoise Heymann, Dominique Heymann, and Frédéric Lézot.
2022. "Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma" Cancers 14, no. 7: 1765.
https://doi.org/10.3390/cancers14071765
APA Style
Muñoz-Garcia, J., Vargas-Franco, J. W., Royer, B. B.-L., Cochonneau, D., Amiaud, J., Heymann, M.-F., Heymann, D., & Lézot, F.
(2022). Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma. Cancers, 14(7), 1765.
https://doi.org/10.3390/cancers14071765
